Moderna dips on flu vaccine RTF letter

FierceBiotechFacing mounting China licensing costs, biopharma buyers turn to AI and local know-how to keep up

FierceBiotechIncyte inks deal with Edison Scientific to train AI through drug discovery

FierceBiotechClinical trial flaws ‘being scaled, not solved’ by AI: report

Endpoints NewsFull-Life Technologies raises $150M; Quince's reboot with pulmonary drug

FierceBiotechMerck inks Keytruda supply pact to support Exelixis’ colorectal cancer trial

PharmaVoiceSummer reads with unexpected lessons for biopharma leaders

BioWorldShanghai Meiyue Biotech discloses new EHMT2 inhibitors

BioWorldConvalife Pharmaceuticals discovers new CFB inhibitors

BioWorldKimia Therapeutics patents new DHX9 inhibitors

BioWorldNew PROTACs reported in Prelude Therapeutics patent

BioWorldBundibugyo is harsh reminder of need for broad vaccine strategies

LabiotechRAS inhibition enters its second wave